For citations:
Novik A.V., Yaremenko E.V., Anokhina E.M., Nehaeva T.L., Semenova A.I., Latipova D.Kh., Protsenko S.A., Baldueva I.A. RECIST 1.1 AND irRC FOR RESPONSE ASSESMENT IN PATIENTS WITH DISSEMINATED CUTANEOUS MELANOMA TREATED WITH IPILIMUMAB OR DENDRITIC CELL VACCINE. Siberian journal of oncology. 2019;18(4):13-20. (In Russ.) https://doi.org/10.21294/1814-4861-2019-18-4-13-20
Email this article 
